Lifestyle plan for heart and health after lymphoma remission
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests a structured lifestyle and survivorship care plan for people who finished treatment for certain lymphoma types and are now in long-term remission. The goal is to support long-term health (including heart-related monitoring) and reduce future risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 50 years old when you first started lymphoma treatment
- Have classical Hodgkin lymphoma, diffuse large B-cell lymphoma, or primary mediastinal large B-cell lymphoma
- Be in complete remission after first-line chemotherapy, with treatment finished at least 3 years ago and within 10 years
- Have had enough doxorubicin (adriamycin) during chemotherapy (at least 200 mg per body area)
- Be able to get an echocardiogram (heart ultrasound) and have it done within 3 months before joining
- Be willing and able to follow all study visits and procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how lymphoma treatment may affect thinking and memory years after therapy. It aims to understand and support long-term survivors.
This trial tests if a heart-protecting drug (dexrazoxane) can prevent heart damage in people getting chemotherapy for certain types of large B-cell lymphoma. It is for patients who already have heart risk factors or a history of heart failure.
This study compares two ways of managing care for older adults with a type of blood cancer called lymphoma. One group gets standard care, the other gets a plan adjusted to their overall health and frailty, which might help them tolerate treatment better.
This study tests whether a Mediterranean-style diet and home exercise plan can improve health and recovery in people who have been treated for non-Hodgkin or Hodgkin lymphoma with chemotherapy. You may also be placed on a waitlist/control group to compare outcomes.
This trial studies a specific treatment plan to see how well it works for adults with newly diagnosed non-Hodgkin lymphoma that has a high amount of disease. It may help by aiming to control lymphoma more effectively, especially when it is widespread.
This study tests whether a supervised exercise program can improve heart health in people who finished treatment for Hodgkin or aggressive non-Hodgkin lymphoma 2–5 years ago. The goal is to see if regular exercise helps your heart recover better after chemotherapy or chest radiation.
Hear when a new Classical Hodgkin Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.